Drugs / Chlorhexidine Gluconate Mouthwash
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03787082 | Dec 2022 → Dec 2023 | diastolic heart failure, pulmonary hypertension | Gladwin, Mark, MD | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chlorhexidine Gluconate Mouthwash | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03787082 ↗ |